Manmeet Singh Soni, Director, COO and CFO, on June 04, 2026, executed a purchase for 50,000 shares in Summit Therapeutics (SMMT) for $722,250. Following the Form 4 filing with the SEC, Soni has control over a total of 3,123,603 common shares of the company, with 3,123,603 shares held directly.
SEC Filing:
Edward Deitzel, Executive Vice President, Chief Regulatory Officer and Chief Compliance Officer, MIAX Exchanges, on June 02, 2026, sold 11,000 shares in Miami International Holdings (MIAX) for $463,760. Following the Form 4 filing with the SEC, Deitzel has control over a total of 116,221 common shares of the company, with 116,221 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1438472/000208067126000008/xslF345X05/wk-form4_1780605876.xml
Hilda Frederique Scharen-Guivel, Director, on June 04, 2026, sold 3,000 shares in Iradimed (IRMD) for $285,000. Following the Form 4 filing with the SEC, Scharen-Guivel has control over a total of 5,598 common shares of the company, with 5,598 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1325618/000195012926000006/xslF345X05/wk-form4_1780604510.xml
Paul J Sarvadi, Director, Chairman of the Board & CEO, on June 03, 2026, executed a purchase for 233,000 shares in Insperity (NSP) for $7,933,650. Following the Form 4 filing with the SEC, Sarvadi has control over a total of 1,805,582 common shares of the company, with 699,670 shares held directly and 1,105,912 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1000753/000100075326000078/xslF345X05/form4.xml